CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies

Objectives. To assess CCL18 and OX40L as biomarkers of interstitial lung disease (ILD) and/or progressive fibrosing (PF-) ILD in idiopathic inflammatory myopathies (IIMs). Methods. Patients with IIMs seen in our center from July 2020 to March 2021 were consecutively enrolled. ILD was detected by hig...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Elisabetta Zanatta, Andrea Martini, Roberto Depascale, Anna Gamba, Marta Tonello, Mariele Gatto, Chiara Giraudo, Elisabetta Balestro, Andrea Doria, Luca Iaccarino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-05-01
Colecção:	Diagnostics
Assuntos:	interstitial lung disease (ILD) idiopathic inflammatory myopathies (IIMs) biomarkers autoantibodies progressive pulmonary fibrosis
Acesso em linha:	https://www.mdpi.com/2075-4418/13/10/1715
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!